Goldman Steven M. 4
4 · Dova Pharmaceuticals Inc. · Filed Jun 3, 2019
Insider Transaction Report
Form 4
Goldman Steven M.
Director
Transactions
- Exercise/Conversion
Common Stock
2019-05-13$7.32/sh+3,668$26,850→ 140,780 total - Exercise/Conversion
Stock Option (right to buy)
2019-01-02−4,583→ 15,585 totalExercise: $7.32Exp: 2027-05-24→ Common Stock (4,583 underlying) - Exercise/Conversion
Common Stock
2019-01-02$7.32/sh+4,583$33,548→ 137,112 total - Exercise/Conversion
Stock Option (right to buy)
2019-05-13−3,668→ 11,917 totalExercise: $7.32Exp: 2027-05-24→ Common Stock (3,668 underlying)
Holdings
- 5,000(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]These shares are held by the Steven M. Goldman Family LLC (the "LLC"), of which the Reporting Person is the Managing Member. The voting and investment decisions of the LLC are made by an independent external asset manager. The Reporting Person disclaims beneficial ownership of the shares held by the LLC except to the extent of his pecuniary interest in the LLC, if any, and the inclusion of these shares on this report shall not be deemed an admission that the Reporting Person beneficially owns the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or any other purpose.
- [F2]The option vests over a period of three years as follows: (i) one-third of the total shares subject to the option shall vested on May 25, 2018, and (ii) 1/36th of total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service with the Issuer on each such date. The option allows for early exercise, subject to the Issuer's repurchase option, with respect to any unvested shares of Common Stock.